ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism

Sodium levothyroxine (LT4) as a monotherapy represents the mainstay of treatment of hypothyroidism, and its use has increased over time. Nevertheless, it faces several potential barriers in its ‘real life’ utilization, and hence its clinical effectiveness may be marred. This is suggested by the freq...

Полное описание

Библиографические подробности

Главные авторы:	Marco Centanni, Leonidas Duntas, Ulla Feldt-Rasmussen, Josef Koehrle, Robin P Peeters, Salman Razvi, Pierpaolo Trimboli, Camilla Virili
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Bioscientifica 2025-07-01
Серии:	European Thyroid Journal
Предметы:	levothyroxine therapy hypothyroidism levothyroxine malabsorption levothyroxine formulations patient adherence
Online-ссылка:	https://etj.bioscientifica.com/view/journals/etj/14/4/ETJ-25-0123.xml
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!